No abstract available
Keywords:
SARS-CoV-2; pulmonary medicine; treatments.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Antibodies, Neutralizing / therapeutic use*
-
COVID-19 Drug Treatment*
-
Cohort Studies
-
Drug Combinations
-
Humans
-
SARS-CoV-2 / drug effects
Substances
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Neutralizing
-
Drug Combinations
-
casirivimab and imdevimab drug combination